The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Prostate Specific Antigen (PSA) Test Market Between 2026 And 2030?
The prostate specific antigen (psa) test market size has seen significant growth in recent years. It is projected to increase from $4.65 billion in 2025 to $5.19 billion in 2026, at a compound annual growth rate (CAGR) of 11.7%. This historical expansion can be attributed to the rising adoption of psa testing in clinical practice, the broadening of laboratory diagnostic services, greater public awareness of prostate cancer screening, the widespread availability of immunoassay-based test kits, and the integration of psa testing into routine medical checkups.
The prostate specific antigen (psa) test market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $8.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.0%. The expansion during this forecast period can be linked to several factors, including the progress in high-precision psa assay technologies, the increasing acceptance of decentralized diagnostic testing, the wider implementation of preventive cancer screening initiatives, growing financial commitments to diagnostic automation, and the rising need for economical screening methods. Key developments expected during the forecast period encompass the wider embrace of routine psa screening programs, an increasing call for point-of-care psa testing, the expanded application of high-sensitivity immunoassays, the broadening of post-treatment monitoring uses, and a heightened emphasis on the early detection of cancer.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12576&type=smp
What Leading Drivers Are Supporting The Prostate Specific Antigen (PSA) Test Market Expansion?
The expanding occurrence of prostate cancer is anticipated to drive the future expansion of the prostate-specific antigen (PSA) test market. Prostate cancer is defined as a disease where cancer originates in the prostate gland, a part of the male and female reproductive systems. The prostate-specific antigen (PSA) test serves as a widely utilized screening method for prostate cancer among men. This test gauges the concentration of PSA in the blood, aiding in timely detection and evaluating risk. As an illustration, reports from March 2023 by the American Society of Clinical Oncology (ASCO), a US-based professional oncology organization, indicated that in the US, around 288,300 men received a prostate cancer diagnosis, and roughly 34,700 people succumbed to the disease in 2023. Consequently, the escalating incidence of prostate cancer is propelling the expansion of the prostate-specific antigen (PSA) test market.
How Is The Prostate Specific Antigen (PSA) Test Market Segmented Across Different Segment Categories?
The prostate specific antigen (psa) test market covered in this report is segmented –
1) By Type: Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types
2) By Application: Screening, Post-Treatment Monitoring, Other Applications
3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End Users
Subsegments:
1) By Clinical Laboratory Improvement Amendments (CLIA): CLIA Waived Tests, Non-CLIA Tests
2) By Enzyme-Linked Immunosorbent Assay (ELISA): Sandwich ELISA Kits, Competitive ELISA Kits
3) By Fluorescence Immunoassay (FIA): Point-Of-Care FIA, Laboratory-Based FIA
4) By Other Types: Chemiluminescent Immunoassay (CLIA), Radioimmunoassay (RIA)
What Emerging Trends Are Seen In The Prostate Specific Antigen (PSA) Test Market?
Major companies active in the prostate-specific antigen (PSA) test market are concentrating on product innovation and launches, such as home testing kits for prostate-specific antigen (PSA), to maintain their market position. Home testing kits are self-administered diagnostic tools that enable individuals to collect samples, perform tests, and obtain results without requiring a visit to a healthcare facility. For instance, in September 2023, Randox, an Ireland-based health and toxicology company, unveiled an at-home testing kit for prostate-specific antigen (PSA). This PSA home test is designed to measure the levels of PSA in the blood, providing an indication of abnormalities within the prostate. PSA, a protein produced by prostate gland cells, when found in elevated levels, can signal various conditions, including an enlarged prostate, prostatitis, or a urinary tract infection, beyond the potential presence of prostate cancer.
Which Organizations Play A Role In The Prostate Specific Antigen (PSA) Test Market Landscape?
Major companies operating in the prostate specific antigen (psa) test market are Siemens AG, F Hoffmann La Roche AG, Abbott Laboratories, Becton Dickinson And Company, PerkinElmer Inc, Beckman Coulter Inc, Bio Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, DiaSorin SpA, OPKO Health Inc, R And D Systems Inc, Meso Scale Diagnostics LLC, Tosoh America Inc, Fujirebio Europe NV, Boditech Med Inc, DRG International Inc, Enzo Life Sciences Inc, RayBiotech Inc, Novus Biologicals LLC, Creative Diagnostics Inc, Elabscience, LifeSpan BioSciences Inc, Accuquik Inc
Get The Full Prostate Specific Antigen (PSA) Test Market Report:
Which Region Holds The Highest Market Share In The Prostate Specific Antigen (PSA) Test Market?
North America was the largest region in the prostate specific antigen (PSA) test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (psa) test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Prostate Specific Antigen (PSA) Test Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Prostate Specific Antigen (PSA) Test Market 2026, By The Business Research Company
Prostate Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report
Prostate Cancer Nuclear Medicine Diagnostics Market Report
Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model